183 related articles for article (PubMed ID: 37768208)
1. Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases.
Ye J; Guo W; Wang C; Egelston CA; D'Apuzzo M; Shankar G; Fakih MG; Lee PP
Cancer Res Commun; 2023 Oct; 3(10):2082-2095. PubMed ID: 37768208
[TBL] [Abstract][Full Text] [Related]
2. Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases.
Wang C; Sandhu J; Ouyang C; Ye J; Lee PP; Fakih M
JAMA Netw Open; 2021 Aug; 4(8):e2118416. PubMed ID: 34369992
[TBL] [Abstract][Full Text] [Related]
3. Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice.
Küçükköse E; Heesters BA; Villaudy J; Verheem A; Cercel M; van Hal S; Boj SF; Borel Rinkes IHM; Punt CJA; Roodhart JML; Laoukili J; Koopman M; Spits H; Kranenburg O
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543378
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy response in microsatellite stable metastatic colorectal cancer is influenced by site of metastases.
Fakih M; Wang C; Sandhu J; Ye J; Egelston C; Li X
Eur J Cancer; 2024 Jan; 196():113437. PubMed ID: 37980853
[TBL] [Abstract][Full Text] [Related]
5. Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma.
Restle D; Dux J; Li X; Byun AJ; Choe JK; Li Y; Vaghjiani RG; Thomas C; Misawa K; Tan KS; Jones DR; Chintala NK; Adusumilli PS
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37349126
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).
Johnson B; Haymaker CL; Parra ER; Soto LMS; Wang X; Thomas JV; Dasari A; Morris VK; Raghav K; Vilar E; Kee BK; Eng C; Parseghian CM; Wolff RA; Lee Y; Lorenzini D; Laberiano-Fernandez C; Verma A; Lang W; Wistuba II; Futreal A; Kopetz S; Overman MJ
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36007963
[TBL] [Abstract][Full Text] [Related]
7. Multi-perspective comparison of the immune microenvironment of primary colorectal cancer and liver metastases.
He Y; Han Y; Fan AH; Li D; Wang B; Ji K; Wang X; Zhao X; Lu Y
J Transl Med; 2022 Oct; 20(1):454. PubMed ID: 36195882
[TBL] [Abstract][Full Text] [Related]
8. Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases.
Lu BY; Gupta R; Aguirre-Ducler A; Gianino N; Wyatt H; Ribeiro M; Chiang VL; Contessa JN; Adeniran AJ; Jilaveanu LB; Kluger HM; Schalper KA; Goldberg SB
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34670827
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 expression in liver metastasis: its clinical significance and discordance with primary tumor in colorectal cancer.
Wei XL; Luo X; Sheng H; Wang Y; Chen DL; Li JN; Wang FH; Xu RH
J Transl Med; 2020 Dec; 18(1):475. PubMed ID: 33308232
[TBL] [Abstract][Full Text] [Related]
10. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern.
Prasanna T; Karapetis CS; Roder D; Tie J; Padbury R; Price T; Wong R; Shapiro J; Nott L; Lee M; Chua YJ; Craft P; Piantadosi C; Sorich M; Gibbs P; Yip D
Acta Oncol; 2018 Nov; 57(11):1438-1444. PubMed ID: 30035653
[TBL] [Abstract][Full Text] [Related]
11. A
Nygaard V; Ree AH; Dagenborg VJ; Børresen-Dale AL; Edwin B; Fretland ÅA; Grzyb K; Haugen MH; Mælandsmo GM; Flatmark K
Cancer Res Commun; 2023 Feb; 3(2):235-244. PubMed ID: 36968142
[TBL] [Abstract][Full Text] [Related]
12. Presence of Tim3
Klapholz M; Drage MG; Srivastava A; Anderson AC
J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692
[TBL] [Abstract][Full Text] [Related]
13. Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer.
Wang E; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Okazaki Y; Kashiwagi S; Tanaka H; Maeda K; Hirakawa K; Ohira M
PLoS One; 2021; 16(7):e0255049. PubMed ID: 34293030
[TBL] [Abstract][Full Text] [Related]
14. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of colorectal cancer liver metastases: the immune/inflammatory infiltrate.
Giuşcă SE; Zugun FE; Târcoveanu E; Carasevici E; Amălinei C; Căruntu ID
Rom J Morphol Embryol; 2010; 51(1):73-9. PubMed ID: 20191123
[TBL] [Abstract][Full Text] [Related]
16. RHAMM in liver metastases of stage IV colorectal cancer with mismatch-repair proficient status correlates with tumor budding, cytotoxic T-cells and PD-1/PD-L1.
Burren S; Reche K; Blank A; Galvàn JA; Dawson H; Berger MD; Zlobec I; Lugli A
Pathol Res Pract; 2021 Jul; 223():153486. PubMed ID: 34051513
[TBL] [Abstract][Full Text] [Related]
17. Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases.
Wood CS; Pennel KAF; Leslie H; Legrini A; Cameron AJ; Melissourgou-Syka L; Quinn JA; van Wyk HC; Hay J; Roseweir AK; Nixon C; Roxburgh CSD; McMillan DC; Biankin AV; Sansom OJ; Horgan PG; Edwards J; Steele CW; Jamieson NB
Cancer Res; 2023 Apr; 83(8):1329-1344. PubMed ID: 37057593
[TBL] [Abstract][Full Text] [Related]
18. Targeting MSS colorectal cancer with immunotherapy: are we turning the corner?
Wang C; Fakih M
Expert Opin Biol Ther; 2021 Oct; 21(10):1347-1357. PubMed ID: 34030532
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases.
Dagenborg VJ; Marshall SE; Yaqub S; Grzyb K; Boye K; Lund-Iversen M; Høye E; Berstad AE; Fretland ÅA; Edwin B; Ree AH; Flatmark K
Cancer Biol Ther; 2020 May; 21(5):432-440. PubMed ID: 32098573
[TBL] [Abstract][Full Text] [Related]
20. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]